Full-Time

Principal Corevalve Therapy Consultant

Posted on 2/18/2025

Medtronic

Medtronic

10,001+ employees

Develops and manufactures medical devices and therapies

Biotechnology
Healthcare

Compensation Overview

$140k - $150kAnnually

+ Sales Incentive Plan

Senior, Expert

Jacksonville, FL, USA

The position requires travel with overnight stays up to 50-75% of the time.

Category
Field Sales
Sales & Account Management

You match the following Medtronic's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Bachelor’s Degree
  • 7+ years medical industry sales experience (selling physician preference products) in healthcare environment
  • 3+ years of B2B sales and 4+ years medical industry sales experience
  • 3+ years MDT TDS experience and 4+ years medical industry sales experience
  • Ability to travel with overnight stay up to 50 - 75% of the time (geography variability)
Responsibilities
  • Territory Management and Account Development
  • Provide quality support to help sites achieve procedural success and for the safe growth of CoreValve
  • Develop and post approval, execute strategies and plans to achieve/exceed sales quota for commercial cases
  • Serve as trusted technical expert for TAVR procedure and products
  • Probe to understand and confirm customers’ needs, handle objections and gain commitment
  • Educate customers to ensure that products are understood and used effectively
  • Represent company at industry conferences and maximize potential by targeting specific customers to gain sales leads
  • Provide quality technical support to help sites achieve procedural success
  • Ensure maximum coverage of all accounts within territory geographic areas to maintain optimum level of exposure and effective time management
  • Participate in physician training and case observations when necessary
  • Develop and maintain accurate account and territory records
  • Identify, establish and maintain productive working relationships with key decision makers, customers and their staff
Desired Qualifications
  • Demonstrated success in previous sales role; indicating a high level of sales performance, influence and selling skills
  • Exceptional business and clinical acumen with prior experience leading a sophisticated cardiac or endovascular procedure
  • Exceptional understanding of cardiac and vascular anatomy, physiology, and pathology
  • Interventional cardiac or vascular experience (wires, balloons, catheters, stents)
  • Strong, proven medical device sales track record with documented growth and achievements
  • Experience managing multiple accounts
  • Successful experience launching a new device
  • Market development experience
  • Experience calling on C-Suite customers
  • Prior experience teaching and educating medical personnel, peers and technical support personnel
  • Imaging interpretation experience (TTE or Trans Esophageal Echocardiography (TEE), CT, Angiograms)
  • Demonstrated success building strong relationships with key therapy users and employees across organizational level
  • Ability to effectively organize and plan travel schedule with frequent last minute requests
  • Previous peer and physician education experience
  • Excellent influencing and consulting skills
  • Excellent interpersonal and written communication skills
  • Ability to make timely and sound decisions

Medtronic provides medical technology, services, and solutions to improve patient care. The company develops a variety of medical devices, including pacemakers, insulin pumps, surgical tools, and neurostimulation devices, which help diagnose, prevent, and treat chronic diseases. These products are used by hospitals and healthcare professionals around the world. Medtronic stands out from competitors by not only focusing on product development but also offering training, patient management programs, and technical support to healthcare providers. The goal of Medtronic is to enhance patient outcomes and lower healthcare costs through comprehensive solutions.

Company Size

10,001+

Company Stage

IPO

Total Funding

$3.2M

Headquarters

Fridley, Minnesota

Founded

1949

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased AI adoption in medical imaging boosts Medtronic's diagnostic device efficiency.
  • Telehealth growth expands opportunities for Medtronic's connected devices and solutions.
  • Personalized medicine trends drive demand for Medtronic's adaptive technologies like BrainSense™ aDBS.

What critics are saying

  • Stricter European regulations may delay Medtronic's product launches.
  • Rising competition in diabetes care from Dexcom and Abbott threatens market share.
  • Supply chain issues, especially in semiconductors, could disrupt Medtronic's device production.

What makes Medtronic unique

  • Medtronic's BrainSense™ aDBS offers personalized Parkinson's treatment, enhancing patient outcomes.
  • The company leads in minimally invasive surgical tools, meeting growing market demand.
  • Medtronic's global presence in over 150 countries strengthens its market reach and influence.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Employee Assistance Program

Wellness Program

Company News

PR Newswire
Feb 18th, 2025
Medtronic Reports Third Quarter Fiscal 2025 Financial Results

Delivering durable revenue growth with strong earnings power; strength in Pulsed Field Ablation, Pacing, Structural Heart, Diabetes, and NeuromodulationGALWAY, Ireland, Feb. 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced financial results for its third quarter (Q3) of fiscal year 2025 (FY25), which ended January 24, 2025.Key Highlights

Surgical Robotics Technology
Feb 13th, 2025
Medtronic Acquires Certain Nano Surface Technology from Nanovis

Medtronic acquires certain nano surface technology from Nanovis.

Retia Medical
Feb 11th, 2025
Retia signs US distribution Agreement for Argos(R) Cardiac Output Monitor with Medtronic

WHITE PLAINS, NEW YORK, UNITED STATES, Febryary 11, 2025 - Retia Medical, an innovator in AI algorithms for patient monitoring and management, announced that it has entered into an agreement with Medtronic plc, a global leader in healthcare technology, to distribute the Argos Cardiac Output Monitor designed to provide healthcare professionals with highly accurate hemodynamic data to support the treatment of high-risk surgical and critically ill patients.

PR Newswire
Feb 5th, 2025
Medtronic To Announce Financial Results For Its Third Quarter Of Fiscal Year 2025

GALWAY, Ireland, Feb. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2025 on Tuesday, February 18, 2025. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's third quarter of fiscal year 2025, which ended on Friday, January 24, 2025. Medtronic will host a video webcast at 7:00 a.m

Stock Titan
Jan 21st, 2025
Medtronic appoints Thierry Piéton as Chief Financial Officer

GALWAY, Ireland, Jan. 21, 2025 /PRNewswire/ - Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that Thierry Piéton has been appointed Chief Financial Officer for the company, effective March 3, 2025.